Search Results for: covid
MiRXES and PT ELION inked landmark MOU to develop blood-based multi-cancer early detection solutions optimized for the Indonesian population
NEWSROOM Stay current with MiRXES Newsroom > Media Releases MiRXES and PT ELION inked landmark MOU to develop blood-based multi-cancer early detection solutions optimized for the Indonesian population SINGAPORE, 29 November 2022 – MiRXES Pte Ltd, a Singapore-headquartered RNA technology company focused on saving lives and improving health economics and outcomes through disease early detection …
MiRXES collaborates with NUHCS and NHCS to launch Southeast Asia’s first Asian-focused multi-center study to advance pulmonary hypertension early detection
NEWSROOM Stay current with MiRXES Newsroom > Media Releases MiRXES collaborates with NUHCS and NHCS to launch Southeast Asia’s first Asian-focused multi-center study to advance pulmonary hypertension early detection Singapore-headquartered biotech MiRXES, NUHCS and NHCS launch SPHERE study to identify biomarkers that are relevant to early detection of pulmonary hypertension with the aim to improve …
Project CADENCE MOU Signing
NEWSROOM Stay current with MiRXES Newsroom > Media Releases MiRXES strengthens global fight against cancer with launch of world’s first research project for a multi-cancer screening test using microRNA and multi-omics technology SINGAPORE, 7 July 2022 – MiRXES Pte Ltd, a Singapore-headquartered biotechnology company, whose mission is to save and improve lives through early, actionable, …
MiRXES Opens Southeast Asia’s First Industry 4.0 In Vitro Diagnostic Manufacturing Facility
NEWSROOM Stay current with MiRXES Newsroom > Media Releases MiRXES Opens Southeast Asia’s First Industry 4.0 In Vitro Diagnostic Manufacturing Facility Singapore, 27 May 2022 – MiRXES Pte Ltd, a Singapore-headquartered biotechnology company, and A*STAR spinoff, focused on saving and improving lives with miRNA-powered cancer early detection tests, announced today the opening of the first …